Therapeutic effect of orally administered microencapsulated oxaliplatin for colorectal cancer

Jemal, 2006, Cancer statistics, 2006, CA Cancer J Clin, 56, 106, 10.3322/canjclin.56.2.106 Wang, 2005, Cellular processing of platinum anticancer drugs, Nat Rev Drug Discov, 4, 307, 10.1038/nrd1691 Wang, 2008, Towards the rational design of platinum(II) and gold(III) complexes as antitumour agents, Dalton Trans, 28, 1521, 10.1039/B715903J Argyriou, 2008, A review on oxaliplatin-induced peripheral nerve damage, Cancer Treat Rev, 34, 368, 10.1016/j.ctrv.2008.01.003 Rabik, 2007, Molecular mechanisms of resistance and toxicity associated with platinating agents, Cancer Treat Rev, 33, 9, 10.1016/j.ctrv.2006.09.006 Pietrangeli, 2006, Persistence of high-dose oxaliplatin-induced neuropathy at long-term follow-up, Eur Neurol, 56, 13, 10.1159/000094376 Michor, 2005, Dynamics of colorectal cancer, Semin Cancer Biol, 15, 484, 10.1016/j.semcancer.2005.06.005 Nagda, 2011, Preparation and characterization of spray-dried mucoadhesive microspheres of ketorolac for nasal administration, Curr Drug Deliv, 21 Choi, 2010, Pluronic/chitosan hydrogels containing epidermal growth factor with wound-adhesive and photo-crosslinkable properties, J Biomed Mater Res A, 95, 564, 10.1002/jbm.a.32848 Jain, 2007, Muco-adhesive multivesicular liposomes as an effective carrier for transmucosal insulin delivery, J Drug Target, 15, 417, 10.1080/10611860701453653 Wu, 2011, Vaginal delivery of siRNA using a novel PEGylated lipoplex-entrapped alginate scaffold system, J Control Release, 155, 418, 10.1016/j.jconrel.2011.02.002 Sahasathian, 2010, Mucoadhesive and floating chitosan-coated alginate beads for the controlled gastric release of amoxicillin, Arch Pharm Res, 33, 889, 10.1007/s12272-010-0612-8 Cho, 2010, Alginate film as a novel post-surgical tissue adhesion barrier, J Biomater Sci Polym Ed, 21, 701, 10.1163/156856209X435835 Penman, 1972, A method for the determination of uronic acid sequence in alginates, Carbohydr Res, 25, 273, 10.1016/S0008-6215(00)81637-7 (FDA) UFaDA, 2006 Igoe, 1983 Wheatley, 2003, Coated alginate microspheres - factors influencing the controlled delivery of macromolecules, J Appl Polym Sci, 43, 2123, 10.1002/app.1991.070431120 Kim, 1992, The controlled release of blue dextran from alginate beads, Int J Pharm, 79, 11, 10.1016/0378-5173(92)90088-J Singh, 1989, Characterization of albumin-alginic acid complex coacervation, J Pharm Pharmacol, 41, 670, 10.1111/j.2042-7158.1989.tb06338.x Baldwin, 2010, Polysaccharide-modified synthetic polymeric biomaterials, Biopolymers, 94, 128, 10.1002/bip.21334 Tonnesen, 2002, Alginate in drug delivery systems, Drug Dev Ind Pharm, 28, 621, 10.1081/DDC-120003853 Peters, 1998, Release from alginate enhances the biological activity of vascular endothelial growth factor, J Biomater Sci Polym Ed, 9, 1267, 10.1163/156856298X00389 Sharma, 2000, Chitosan, a drug carrier for the 21st century: a review, Stp Pharma Sci, 10, 5 Su, 1992, Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene, Science, 256, 668, 10.1126/science.1350108 Love, 2010, Lipid-like materials for low-dose, in vivo gene silencing, Proc Natl Acad Sci USA, 107, 1864, 10.1073/pnas.0910603106 Huerta, 2003, Intestinal polyp formation in the Apcmin mouse: effects of levels of dietary calcium and altered vitamin D homeostasis, Dig Dis Sci, 48, 870, 10.1023/A:1023083025595 Terhaar Sive Droste, 2009, Colonoscopic yield of colorectal neoplasia in daily clinical practice, World J Gastroenterol, 15, 1085, 10.3748/wjg.15.1085 Rominiyi, 2011, Colon cancer presenting with polymyositis-A case report, Int J Surg Case Rep, 2, 225, 10.1016/j.ijscr.2011.07.004 Sharma, 1995, Colorectal manifestations of endocrine disease, Dis Colon Rectum, 38, 318, 10.1007/BF02055611 Mecklenburg, 2005, Recurrent severe gastrointestinal bleeding and malabsorption due to extensive habitual megacolon, World J Gastroenterol, 11, 7686, 10.3748/wjg.v11.i48.7686 MacDermott, 1996, Alterations of the mucosal immune system in inflammatory bowel disease, J Gastroenterol, 31, 907, 10.1007/BF02358624 McClellan, 2011, Intestinal inflammatory cytokine response in relation to tumorigenesis in the Apc(Min/+) mouse, Cytokine, 57, 113 Playford, 2005, Cytokines and growth factor modulators in intestinal inflammation and repair, J Pathol, 205, 417, 10.1002/path.1722 Fuss, 2003, Cytokine network in inflammatory bowel disease, Curr Drug Targets Inflamm Allergy, 2, 101, 10.2174/1568010033484197 Judd, 2011, Update of fecal markers of inflammation in inflammatory bowel disease, J Gastroenterol Hepatol, 26, 1493, 10.1111/j.1440-1746.2011.06846.x Lee, 2011, High-sensitivity C-reactive protein and cancer, J Epidemiol, 21, 161 Kim, 2009, Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer, BMC Cancer, 9, 155, 10.1186/1471-2407-9-155 Scagliotti, 2002, Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer, J Clin Oncol, 20, 4285, 10.1200/JCO.2002.02.068 Monk, 2009, Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study, J Clin Oncol, 27, 4649, 10.1200/JCO.2009.21.8909 Zachos, 2010, Systemic therapy of metastatic bladder cancer in the molecular era: current status and future promise, Expert Opin Investig Drugs, 19, 875, 10.1517/13543784.2010.496450 Moser, 1990, A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse, Science, 247, 322, 10.1126/science.2296722 Perkins, 2002, Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis, Cancer Epidemiol Biomarkers Prev, 11, 535 Corpet, 2003, Point: from animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system, Cancer Epidemiol Biomarkers Prev, 12, 391 Sethi, 2012, Multifaceted link between cancer and inflammation, Biosci Rep, 32, 1, 10.1042/BSR20100136 Lowe, 2011, Chronic inflammation and immunologic-based constraints in malignant disease, Immunotherapy, 3, 1265, 10.2217/imt.11.113 Hakansson, 2011, Colorectal oncogenesis and inflammation in a rat model based on chronic inflammation due to cycling DSS treatments, Gastroenterol Res Pract, 924045 Macarthur, 2004, Inflammation and cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy, Am J Physiol Gastrointest Liver Physiol, 286, G515, 10.1152/ajpgi.00475.2003 Langholz, 1994, Course of ulcerative colitis: analysis of changes in disease activity over years, Gastroenterology, 107, 3, 10.1016/0016-5085(94)90054-X Kinoshita, 1999, Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma, Cancer, 85, 2526, 10.1002/(SICI)1097-0142(19990615)85:12<2526::AID-CNCR6>3.0.CO;2-3 Tomita, 2002, Bovine lactoferrin and lactoferricin derived from milk: production and applications, Biochem Cell Biol, 80, 109, 10.1139/o01-230 Sugi, 1996, Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins, Am J Gastroenterol, 91, 927 Kane, 2003, Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation, Am J Gastroenterol, 98, 1309, 10.1111/j.1572-0241.2003.07458.x Baveye, 1999, Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process, Clin Chem Lab Med, 37, 281, 10.1515/CCLM.1999.049 Shiu, 2008, Is C-reactive protein a prognostic factor of colorectal cancer?, Dis Colon Rectum, 51, 443, 10.1007/s10350-007-9133-z van de Poll, 2011, C-reactive protein concentration is associated with prognosis in patients suffering from peritoneal carcinomatosis of colorectal origin, Int J Colorectal Dis, 26, 1067, 10.1007/s00384-011-1187-7 Dymicka-Piekarska, 2007, Relationship between soluble P-selectin and inflammatory factors (interleukin-6 and C-reactive protein) in colorectal cancer, Thromb Res, 120, 585, 10.1016/j.thromres.2006.11.002 Dockrell, 2001, Apoptotic cell death in the pathogenesis of infectious diseases, J Infect, 42, 227 Oshima, 2002, COX selectivity and animal models for colon cancer, Curr Pharm Des, 8, 1021, 10.2174/1381612023394953 Arai, 2005, Immunohistochemical analysis of cleaved caspase-3 detects high level of apoptosis frequently in diffuse large B-cell lymphomas of the central nervous system, Pathol Int, 55, 122, 10.1111/j.1440-1827.2005.01808.x Gerdes, 1984, Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67, Hematol Oncol, 2, 365, 10.1002/hon.2900020406